We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T Turnover 6.4%
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+695.64%
AUM
$254B
AUM Growth
+$10.5B
Cap. Flow
+$4.16B
Cap. Flow %
1.64%
Top 10 Hldgs %
15.87%
Holding
4,218
New
134
Increased
2,755
Reduced
887
Closed
134
Avg Time Held
3.2 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.9 years

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$213M
2
MO icon
Altria Group
MO
+$206M
3
XOM icon
ExxonMobil
XOM
+$105M
4
MSFT icon
Microsoft
MSFT
+$86.8M
5
META icon
Meta Platforms (Facebook)
META
+$75.5M

Sector Composition

Rank Sector Weight
1 Technology 16.07%
2 Financials 16.07%
3 Healthcare 14.35%
4 Industrials 10.62%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
POT
3376
DELISTED
Potash Corp Of Saskatchewan
POT
$400K ﹤0.01%
24,588
-540
-2% -$8.94K
2013 Q2
16 quarters
AXSM icon
3377
Axsome Therapeutics
AXSM
$8.21B
$399K ﹤0.01%
72,694
+14,891
+26% +$62.3K
2016 Q1
5 quarters
VRDN icon
3378
Viridian Therapeutics
VRDN
$2.19B
$398K ﹤0.01%
2,055
+1,258
+158% +$212K
2017 Q1
1 quarter
IMUX icon
3379
Immunic
IMUX
$93.9M
$397K ﹤0.01%
342
-89
-21% -$119K
2014 Q2
12 quarters
CIG icon
3380
CEMIG Preferred Shares
CIG
$6.52B
$395K ﹤0.01%
324,209
+26,427
+9% +$35K
2013 Q2
16 quarters
CDI
3381
DELISTED
CDI Corp.
CDI
$395K ﹤0.01%
67,558
– –
2013 Q2
16 quarters
IX icon
3382
ORIX
IX
$39.7B
$393K ﹤0.01%
25,250
+6,440
+34% +$101K
2016 Q4
2 quarters
RMT icon
3383
Royce Micro-Cap Trust
RMT
$686M
$393K ﹤0.01%
+45,461
New +$390K
2017 Q2
0 quarters
UMH.PRA.CL icon
3384
DELISTED
Umh Properties Inc
UMH.PRA.CL
$392K ﹤0.01%
15,070
-740
-5% -$19.2K
2015 Q3
7 quarters
ARQL
3385
DELISTED
Arqule Inc
ARQL
$390K ﹤0.01%
315,221
-8,459
-3% -$9.23K
2013 Q2
16 quarters
BBRG
3386
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$386K ﹤0.01%
83,916
-1,457
-2% -$6.89K
2013 Q2
16 quarters
PRCP
3387
DELISTED
Perceptron Inc
PRCP
$383K ﹤0.01%
52,634
+1,922
+4% +$15.2K
2013 Q2
16 quarters
WHLR icon
3388
Wheeler Real Estate Investment Trust
WHLR
$216K
– –
0
– –
2014 Q3
11 quarters
UBP.PRG.CL
3389
DELISTED
Urstadt Biddle Properties Inc. 6.75% Series G Cumulative Redeemable Preferred Stock, liquidation pre
UBP.PRG.CL
$377K ﹤0.01%
14,293
-150
-1% -$3.88K
2015 Q3
7 quarters
TLPH icon
3390
Talphera
TLPH
$56.1M
$376K ﹤0.01%
8,763
-2,545
-23% -$129K
2013 Q2
16 quarters
BT
3391
DELISTED
BT Group plc (ADR)
BT
$376K ﹤0.01%
19,438
-89
-0.5% -$1.75K
2013 Q4
14 quarters
CTIC
3392
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$376K ﹤0.01%
113,682
-3,838
-3% -$14.9K
2013 Q2
16 quarters
KEG
3393
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$376K ﹤0.01%
+19,579
New +$406K
2017 Q2
0 quarters
MUFG icon
3394
Mitsubishi UFJ Financial
MUFG
$247B
$375K ﹤0.01%
55,669
+13,144
+31% +$83.7K
2013 Q4
14 quarters
ATYR icon
3395
aTyr Pharma
ATYR
$17.8M
$375K ﹤0.01%
7,779
-234
-3% -$11K
2015 Q3
7 quarters
HBIO icon
3396
Harvard Bioscience
HBIO
$36.4M
$374K ﹤0.01%
14,679
-581
-4% -$14.4K
2013 Q2
16 quarters
USAK
3397
DELISTED
USA Truck Inc
USAK
$374K ﹤0.01%
43,288
-14,610
-25% -$100K
2013 Q2
16 quarters
GNTY icon
3398
DELISTED
Guaranty Bancshares
GNTY
$373K ﹤0.01%
+12,874
New +$372K
2017 Q2
0 quarters
GEN icon
3399
DELISTED
Genesis Healthcare, Inc.
GEN
$373K ﹤0.01%
214,493
+3,381
+2% +$7.18K
2015 Q2
8 quarters
UONEK icon
3400
Urban One Class D
UONEK
$17.4M
$372K ﹤0.01%
16,546
-5,032
-23% -$126K
2013 Q2
16 quarters

Similar funds

Geode Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
  • Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
  • Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
  • Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
  • Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
  • Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
  • Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.